Table 1. Clinical characteristics of the included MPM-patients (TCGA-set and LP-WGS-set).
Patient characteristics | Absolute amount (percentage) | |
---|---|---|
TCGA (N = 85) | LP-WGS (N = 21) | |
Gender Male Female |
69 (81%) 16 (19%) |
19 (90%) 2 (10%) |
Age at diagnosis Before or at the age of 60 After the age of 60 Unknown |
32 (38%) 53 (62%) 0 (0%) |
9 (43%) 10 (48%) 2 (10%) |
History of asbestos exposure Yes No Unknown |
54 (64%) 14 (16%) 17 (20%) |
12 (57%) 0 (0%) 9 (43%) |
Histologic diagnosis Epithelioid mesothelioma Non-epithelioid mesothelioma Unknown |
56 (66%) 24 (28%) 5 (6%) |
18 (86%) 3 (14%) 0 (0%) |
Platinum/pemetrexed treatment prior to tissue collection No Yes |
85 (100%) 0 (0%) |
10 (48%) 11 (52%) |
Time to death or last follow-up Less than 36 months More than 36 months Unknown |
73 (86%) 11 (13%) 1 (1%) |
16 (76%) 3 (14%) 2 (10%) |
Vital status Dead Alive |
56 (66%) 29 (34%) |
15 (71%) 6 (29%) |